Mechanism of Chemoreflex and Baroreflex alterations causing Postural Tachycardia Syndrome in POTS patients with orthostatic hyperpnea and hypocapnia.

化学反射和压力感受反射改变引起体位性心动过速综合征的 POTS 患者直立性呼吸过度和低碳酸血症的机制。

基本信息

  • 批准号:
    10705326
  • 负责人:
  • 金额:
    $ 70.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-23 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Postural tachycardia syndrome (POTS) is chronic orthostatic intolerance with excessive upright tachycardia without hypotension and occurs mostly in young females (>85%). Symptoms are lightheadedness, fatigue, cognitive loss, and dyspnea with hyperpneic hypocapnia and ventilatory instability in approximately 50% of our new POTS patients. Our recent studies support an increased hypoxic ventilatory response, sympathoexcitation with sensitization of the carotid body peripheral chemoreflex. Hypocapnia alone produces tachycardia and reduces cerebral blood flow (CBF) engendering many POTS symptoms. Unlike voluntary hyperventilation, hyperpneic POTS is related to decreased central blood volume and cardiac output, increased systemic vascular resistance and BP, splanchnic blood pooling, and a shift in the sigmoidal baroreflex relation that favors tachycardia even while supine. Carotid body sensitivity is highly plastic and can be rapidly conditioned by chronic intermittent hypoxia or by “stagnant hypoxia” - recurrent ischemia of the carotid body. Stagnant hypoxia can be produced by “initial orthostatic hypotension” (IOH) comprising a transient fall in BP and CBF on standing. IOH is abnormal in POTS with a paradoxical decrease in cerebral conductance indicating impaired cerebral autoregulation. We hypothesize that a mechanism for the genesis of POTS involves carotid body sensitization initiated by recurrent IOH results in hyperpneic hypocapnia driving tachycardia directly and indirectly by resetting arterial baroreflexes. We will compare female POTS patients aged 15 to 39 years with (N=40) and without (N=40) orthostatic hyperpnea, to healthy volunteers (N=40) with the following aims: 1. To test orthostatic cardiorespiratory responses to determine whether prolonged IOH precedes upright hypocapnia in hyperpneic POTS but not in controls or non-hyperpneic POTS. Cerebral blood flow, respiratory and hemodynamic measurements, investigating splanchnic blood flow and measuring changes of CBV, regional blood volumes, and cardiac output during a 10 min stand to quantify IOH, and a 10 min tilt test to 70⁰ to quantitate cardiorespiratory changes will allow us to stratify hyperpneic and non-hyperpneic POTS patients. 2.To test if chemoreflex sensitization of ventilation and sympathetic activity are abnormal when supine and upright (at 45o) and how that interacts with Oxford measured cardiovagal and sympathetic baroreflexes under controlled gas conditions: isocapnic hypoxia and isocapnic hyperoxia to measure carotid body reflex; hyperoxic isocapnia and hyperoxic hypercapnia to measure central chemoreflexes. Hyperoxia silences peripheral chemoreceptors and will normalize baroreflex and tilt responses. 3. To employ pharmaceutical modulation of the chemoreflex to elucidate mechanisms of hyperpneic POTS, with the potential of determining treatment modalities to reduce chemoreflex sensitivity and hyperpnea – using an angiotensin type 1 receptor blocker, dietary nitrate to donate NO, and an adenosine receptor antagonist.
项目摘要/摘要 姿势心动过速综合征(POTS)是慢性静态肠道,过量直立 心动过速没有低血压,主要发生在年轻女性中(> 85%)。症状是头晕, 疲劳,认知损失和呼吸困难,呼吸症和通气不稳定性大约 我们的新锅患者中有50%。我们最近的研究支持增加的低氧通气反应, 颈动脉体外周化学反射的敏感性。单独产生的低碳酸氢菌就会产生 心动过速并减少了脑血流(CBF),引起了许多花盆症状。与自愿 过度换气,蜂窝盆与中枢血量减少和心脏输出有关,增加 全身性血管抗性和BP,固定型血液集合以及Sigmoidal baroreflex关系的变化 即使在仰卧时,这也有利于心动过速。颈动脉身体灵敏度高度塑性,可以迅速 由慢性间歇性缺氧或“停滞缺氧” - 颈动脉体的复发性缺血来调节。 停滞的缺氧可以通过“初始体位低血压”(IOH)产生,以完成BP的瞬时下降 和CBF站立。 IOH的盆中异常,脑电导矛盾降低 表明脑自动调节受损。 我们假设盆栽起源的一种机制涉及颈动脉身体灵敏度 通过反复发作的IOH导致直接和间接地驱动心动过速的超脑肾上腺素。 动脉压力反射。我们将比较15至39岁的雌性锅患者(n = 40),没有 (n = 40)正静态嗜睡,对健康的志愿者(n = 40),其目的是: 1。测试定位性心脏呼吸反应以确定延长ioH是否直立 蜂窝盆中的低碳酸盐,但没有在对照或非hy骨盆中。脑血流,呼吸道 和血液动力学测量,研究模脑血流并测量CBV的变化, 区域血量和10分钟内的心脏输出以量化IOH,并进行10分钟的倾斜测试至70⁰ 为了量化心肺变化,我们可以分层呼吸症和非脾盆患者。 2.测试仰卧和交感神经的化学反射敏感性是否异常 直立(45o)以及与牛津的相互作用如何测量的心脏和富有同情心 受控气体条件:异位症缺氧和等含量高氧,以测量颈动脉体反射;高氧气 高氧沉默周围 化学感受器并将标准化压力反射和倾斜反应。 3。采用化学反射的物理调节来阐明蜂窝盆的机制, 具有确定治疗方式的潜力,以降低化学反射敏感性和倍增性 - 使用 血管紧张素1型受体阻滞剂,饮食中的硝酸盐捐赠NO和腺苷受体拮抗剂。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A framework to simplify paediatric syncope diagnosis.
  • DOI:
    10.1007/s00431-023-05114-w
  • 发表时间:
    2023-11
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Stewart, Julian M.;van Dijk, J. Gert;Balaji, Seshadri;Sutton, Richard
  • 通讯作者:
    Sutton, Richard
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARVIN S MEDOW其他文献

MARVIN S MEDOW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARVIN S MEDOW', 18)}}的其他基金

Reducing Orthostatic Intolerance with Oral Rehydration in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
通过口服补液减少肌痛性脑脊髓炎/慢性疲劳综合征患者的体位不耐受
  • 批准号:
    9207020
  • 财政年份:
    2016
  • 资助金额:
    $ 70.86万
  • 项目类别:
DEVELOPMENT OF RENAL AMINO ACID TRANSPORT
肾脏氨基酸运输的发展
  • 批准号:
    3233888
  • 财政年份:
    1984
  • 资助金额:
    $ 70.86万
  • 项目类别:
DEVELOPMENT OF RENAL AMINO ACID TRANSPORT
肾脏氨基酸运输的发展
  • 批准号:
    3154063
  • 财政年份:
    1984
  • 资助金额:
    $ 70.86万
  • 项目类别:

相似海外基金

PGI2 restrains immunopathogenesis in hypertension
PGI2 抑制高血压的免疫发病机制
  • 批准号:
    10731402
  • 财政年份:
    2023
  • 资助金额:
    $ 70.86万
  • 项目类别:
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis
靶向平滑肌细胞 BMAL1 作为抗再狭窄的新治疗策略
  • 批准号:
    10561398
  • 财政年份:
    2023
  • 资助金额:
    $ 70.86万
  • 项目类别:
Endothelial Piezo1 channel and cerebral blood flow control
内皮Piezo1通道与脑血流控制
  • 批准号:
    10719633
  • 财政年份:
    2023
  • 资助金额:
    $ 70.86万
  • 项目类别:
The role of Sertad4 in pathologic cardiac remodeling.
Sertad4 在病理性心脏重塑中的作用。
  • 批准号:
    10642929
  • 财政年份:
    2022
  • 资助金额:
    $ 70.86万
  • 项目类别:
Role of cadherin-11 in kidney fibrosis
cadherin-11在肾纤维化中的作用
  • 批准号:
    10688739
  • 财政年份:
    2022
  • 资助金额:
    $ 70.86万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了